ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prescription Arthritis Medications Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-39T10333
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global and United States Prescription Arthritis Medications Market Report Forecast 2022 2028
BUY CHAPTERS

Global Prescription Arthritis Medications Market Research Report 2025

Code: QYRE-Auto-39T10333
Report
September 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott
Amgen Inc
Boehringer Ingelheim
Horizon Pharma
Novartis
Pfizer Inc
Regeneron

Prescription Arthritis Medications Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Prescription Arthritis Medications Market

Prescription Arthritis Medications Market

The global market for Prescription Arthritis Medications was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Arthritis medicines are generally very effective in helping people with arthritis to manage joint pain and other symptoms.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prescription Arthritis Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Arthritis Medications.
The Prescription Arthritis Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prescription Arthritis Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prescription Arthritis Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Prescription Arthritis Medications Market Report

Report Metric Details
Report Name Prescription Arthritis Medications Market
CAGR 5%
Segment by Type
  • Oral
  • Topical
Segment by Application
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Amgen, Boehringer Ingelheim, Horizon Pharma, Novartis, Pfizer, Regeneron
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Prescription Arthritis Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Prescription Arthritis Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Prescription Arthritis Medications Market report?

Ans: The main players in the Prescription Arthritis Medications Market are Abbott, Amgen, Boehringer Ingelheim, Horizon Pharma, Novartis, Pfizer, Regeneron

What are the Application segmentation covered in the Prescription Arthritis Medications Market report?

Ans: The Applications covered in the Prescription Arthritis Medications Market report are Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

What are the Type segmentation covered in the Prescription Arthritis Medications Market report?

Ans: The Types covered in the Prescription Arthritis Medications Market report are Oral, Topical

1 Prescription Arthritis Medications Market Overview
1.1 Product Definition
1.2 Prescription Arthritis Medications by Type
1.2.1 Global Prescription Arthritis Medications Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral
1.2.3 Topical
1.3 Prescription Arthritis Medications by Application
1.3.1 Global Prescription Arthritis Medications Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Prescription Arthritis Medications Market Size Estimates and Forecasts
1.4.1 Global Prescription Arthritis Medications Revenue 2020-2031
1.4.2 Global Prescription Arthritis Medications Sales 2020-2031
1.4.3 Global Prescription Arthritis Medications Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Prescription Arthritis Medications Market Competition by Manufacturers
2.1 Global Prescription Arthritis Medications Sales Market Share by Manufacturers (2020-2025)
2.2 Global Prescription Arthritis Medications Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Prescription Arthritis Medications Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Prescription Arthritis Medications, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prescription Arthritis Medications, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prescription Arthritis Medications, Product Type & Application
2.7 Global Key Manufacturers of Prescription Arthritis Medications, Date of Enter into This Industry
2.8 Global Prescription Arthritis Medications Market Competitive Situation and Trends
2.8.1 Global Prescription Arthritis Medications Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Prescription Arthritis Medications Players Market Share by Revenue
2.8.3 Global Prescription Arthritis Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prescription Arthritis Medications Market Scenario by Region
3.1 Global Prescription Arthritis Medications Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Prescription Arthritis Medications Sales by Region: 2020-2031
3.2.1 Global Prescription Arthritis Medications Sales by Region: 2020-2025
3.2.2 Global Prescription Arthritis Medications Sales by Region: 2026-2031
3.3 Global Prescription Arthritis Medications Revenue by Region: 2020-2031
3.3.1 Global Prescription Arthritis Medications Revenue by Region: 2020-2025
3.3.2 Global Prescription Arthritis Medications Revenue by Region: 2026-2031
3.4 North America Prescription Arthritis Medications Market Facts & Figures by Country
3.4.1 North America Prescription Arthritis Medications Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Prescription Arthritis Medications Sales by Country (2020-2031)
3.4.3 North America Prescription Arthritis Medications Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prescription Arthritis Medications Market Facts & Figures by Country
3.5.1 Europe Prescription Arthritis Medications Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Prescription Arthritis Medications Sales by Country (2020-2031)
3.5.3 Europe Prescription Arthritis Medications Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prescription Arthritis Medications Market Facts & Figures by Region
3.6.1 Asia Pacific Prescription Arthritis Medications Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Prescription Arthritis Medications Sales by Region (2020-2031)
3.6.3 Asia Pacific Prescription Arthritis Medications Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prescription Arthritis Medications Market Facts & Figures by Country
3.7.1 Latin America Prescription Arthritis Medications Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Prescription Arthritis Medications Sales by Country (2020-2031)
3.7.3 Latin America Prescription Arthritis Medications Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prescription Arthritis Medications Market Facts & Figures by Country
3.8.1 Middle East and Africa Prescription Arthritis Medications Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Prescription Arthritis Medications Sales by Country (2020-2031)
3.8.3 Middle East and Africa Prescription Arthritis Medications Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Prescription Arthritis Medications Sales by Type (2020-2031)
4.1.1 Global Prescription Arthritis Medications Sales by Type (2020-2025)
4.1.2 Global Prescription Arthritis Medications Sales by Type (2026-2031)
4.1.3 Global Prescription Arthritis Medications Sales Market Share by Type (2020-2031)
4.2 Global Prescription Arthritis Medications Revenue by Type (2020-2031)
4.2.1 Global Prescription Arthritis Medications Revenue by Type (2020-2025)
4.2.2 Global Prescription Arthritis Medications Revenue by Type (2026-2031)
4.2.3 Global Prescription Arthritis Medications Revenue Market Share by Type (2020-2031)
4.3 Global Prescription Arthritis Medications Price by Type (2020-2031)
5 Segment by Application
5.1 Global Prescription Arthritis Medications Sales by Application (2020-2031)
5.1.1 Global Prescription Arthritis Medications Sales by Application (2020-2025)
5.1.2 Global Prescription Arthritis Medications Sales by Application (2026-2031)
5.1.3 Global Prescription Arthritis Medications Sales Market Share by Application (2020-2031)
5.2 Global Prescription Arthritis Medications Revenue by Application (2020-2031)
5.2.1 Global Prescription Arthritis Medications Revenue by Application (2020-2025)
5.2.2 Global Prescription Arthritis Medications Revenue by Application (2026-2031)
5.2.3 Global Prescription Arthritis Medications Revenue Market Share by Application (2020-2031)
5.3 Global Prescription Arthritis Medications Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Prescription Arthritis Medications Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Prescription Arthritis Medications Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Company Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Prescription Arthritis Medications Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amgen Prescription Arthritis Medications Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Prescription Arthritis Medications Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boehringer Ingelheim Prescription Arthritis Medications Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Horizon Pharma
6.4.1 Horizon Pharma Company Information
6.4.2 Horizon Pharma Description and Business Overview
6.4.3 Horizon Pharma Prescription Arthritis Medications Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Horizon Pharma Prescription Arthritis Medications Product Portfolio
6.4.5 Horizon Pharma Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Company Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Prescription Arthritis Medications Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis Prescription Arthritis Medications Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Company Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Prescription Arthritis Medications Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Pfizer Prescription Arthritis Medications Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Regeneron
6.7.1 Regeneron Company Information
6.7.2 Regeneron Description and Business Overview
6.7.3 Regeneron Prescription Arthritis Medications Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Regeneron Prescription Arthritis Medications Product Portfolio
6.7.5 Regeneron Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prescription Arthritis Medications Industry Chain Analysis
7.2 Prescription Arthritis Medications Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prescription Arthritis Medications Production Mode & Process Analysis
7.4 Prescription Arthritis Medications Sales and Marketing
7.4.1 Prescription Arthritis Medications Sales Channels
7.4.2 Prescription Arthritis Medications Distributors
7.5 Prescription Arthritis Medications Customer Analysis
8 Prescription Arthritis Medications Market Dynamics
8.1 Prescription Arthritis Medications Industry Trends
8.2 Prescription Arthritis Medications Market Drivers
8.3 Prescription Arthritis Medications Market Challenges
8.4 Prescription Arthritis Medications Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Abbott
Amgen Inc
Boehringer Ingelheim
Horizon Pharma
Novartis
Pfizer Inc
Regeneron
List of Tables
 Table 1. Global Prescription Arthritis Medications Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Prescription Arthritis Medications Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Prescription Arthritis Medications Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Prescription Arthritis Medications Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Prescription Arthritis Medications Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Prescription Arthritis Medications Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Prescription Arthritis Medications Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Prescription Arthritis Medications Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Prescription Arthritis Medications, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Prescription Arthritis Medications, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Prescription Arthritis Medications, Product Type & Application
 Table 12. Global Key Manufacturers of Prescription Arthritis Medications, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Prescription Arthritis Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Arthritis Medications as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Prescription Arthritis Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Prescription Arthritis Medications Sales by Region (2020-2025) & (K Units)
 Table 18. Global Prescription Arthritis Medications Sales Market Share by Region (2020-2025)
 Table 19. Global Prescription Arthritis Medications Sales by Region (2026-2031) & (K Units)
 Table 20. Global Prescription Arthritis Medications Sales Market Share by Region (2026-2031)
 Table 21. Global Prescription Arthritis Medications Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Prescription Arthritis Medications Revenue Market Share by Region (2020-2025)
 Table 23. Global Prescription Arthritis Medications Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Prescription Arthritis Medications Revenue Market Share by Region (2026-2031)
 Table 25. North America Prescription Arthritis Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Prescription Arthritis Medications Sales by Country (2020-2025) & (K Units)
 Table 27. North America Prescription Arthritis Medications Sales by Country (2026-2031) & (K Units)
 Table 28. North America Prescription Arthritis Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Prescription Arthritis Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Prescription Arthritis Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Prescription Arthritis Medications Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Prescription Arthritis Medications Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Prescription Arthritis Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Prescription Arthritis Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Prescription Arthritis Medications Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Prescription Arthritis Medications Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Prescription Arthritis Medications Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Prescription Arthritis Medications Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Prescription Arthritis Medications Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Prescription Arthritis Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Prescription Arthritis Medications Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Prescription Arthritis Medications Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Prescription Arthritis Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Prescription Arthritis Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Prescription Arthritis Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Prescription Arthritis Medications Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Prescription Arthritis Medications Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Prescription Arthritis Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Prescription Arthritis Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Prescription Arthritis Medications Sales (K Units) by Type (2020-2025)
 Table 51. Global Prescription Arthritis Medications Sales (K Units) by Type (2026-2031)
 Table 52. Global Prescription Arthritis Medications Sales Market Share by Type (2020-2025)
 Table 53. Global Prescription Arthritis Medications Sales Market Share by Type (2026-2031)
 Table 54. Global Prescription Arthritis Medications Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Prescription Arthritis Medications Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Prescription Arthritis Medications Revenue Market Share by Type (2020-2025)
 Table 57. Global Prescription Arthritis Medications Revenue Market Share by Type (2026-2031)
 Table 58. Global Prescription Arthritis Medications Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Prescription Arthritis Medications Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Prescription Arthritis Medications Sales (K Units) by Application (2020-2025)
 Table 61. Global Prescription Arthritis Medications Sales (K Units) by Application (2026-2031)
 Table 62. Global Prescription Arthritis Medications Sales Market Share by Application (2020-2025)
 Table 63. Global Prescription Arthritis Medications Sales Market Share by Application (2026-2031)
 Table 64. Global Prescription Arthritis Medications Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Prescription Arthritis Medications Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Prescription Arthritis Medications Revenue Market Share by Application (2020-2025)
 Table 67. Global Prescription Arthritis Medications Revenue Market Share by Application (2026-2031)
 Table 68. Global Prescription Arthritis Medications Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Prescription Arthritis Medications Price (USD/Unit) by Application (2026-2031)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Abbott Prescription Arthritis Medications Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Amgen Company Information
 Table 76. Amgen Description and Business Overview
 Table 77. Amgen Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Amgen Prescription Arthritis Medications Product
 Table 79. Amgen Recent Developments/Updates
 Table 80. Boehringer Ingelheim Company Information
 Table 81. Boehringer Ingelheim Description and Business Overview
 Table 82. Boehringer Ingelheim Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Boehringer Ingelheim Prescription Arthritis Medications Product
 Table 84. Boehringer Ingelheim Recent Developments/Updates
 Table 85. Horizon Pharma Company Information
 Table 86. Horizon Pharma Description and Business Overview
 Table 87. Horizon Pharma Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Horizon Pharma Prescription Arthritis Medications Product
 Table 89. Horizon Pharma Recent Developments/Updates
 Table 90. Novartis Company Information
 Table 91. Novartis Description and Business Overview
 Table 92. Novartis Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Novartis Prescription Arthritis Medications Product
 Table 94. Novartis Recent Developments/Updates
 Table 95. Pfizer Company Information
 Table 96. Pfizer Description and Business Overview
 Table 97. Pfizer Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Pfizer Prescription Arthritis Medications Product
 Table 99. Pfizer Recent Developments/Updates
 Table 100. Regeneron Company Information
 Table 101. Regeneron Description and Business Overview
 Table 102. Regeneron Prescription Arthritis Medications Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Regeneron Prescription Arthritis Medications Product
 Table 104. Regeneron Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Prescription Arthritis Medications Distributors List
 Table 108. Prescription Arthritis Medications Customers List
 Table 109. Prescription Arthritis Medications Market Trends
 Table 110. Prescription Arthritis Medications Market Drivers
 Table 111. Prescription Arthritis Medications Market Challenges
 Table 112. Prescription Arthritis Medications Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Prescription Arthritis Medications
 Figure 2. Global Prescription Arthritis Medications Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Prescription Arthritis Medications Market Share by Type: 2024 & 2031
 Figure 4. Oral Product Picture
 Figure 5. Topical Product Picture
 Figure 6. Global Prescription Arthritis Medications Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Prescription Arthritis Medications Market Share by Application: 2024 & 2031
 Figure 8. Hospital Pharmacies
 Figure 9. Online Pharmacies
 Figure 10. Retail Pharmacies
 Figure 11. Global Prescription Arthritis Medications Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Prescription Arthritis Medications Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Prescription Arthritis Medications Sales (2020-2031) & (K Units)
 Figure 14. Global Prescription Arthritis Medications Average Price (USD/Unit) & (2020-2031)
 Figure 15. Prescription Arthritis Medications Report Years Considered
 Figure 16. Prescription Arthritis Medications Sales Share by Manufacturers in 2024
 Figure 17. Global Prescription Arthritis Medications Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Prescription Arthritis Medications Players: Market Share by Revenue in Prescription Arthritis Medications in 2024
 Figure 19. Prescription Arthritis Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Prescription Arthritis Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Prescription Arthritis Medications Sales Market Share by Country (2020-2031)
 Figure 22. North America Prescription Arthritis Medications Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Prescription Arthritis Medications Sales Market Share by Country (2020-2031)
 Figure 26. Europe Prescription Arthritis Medications Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Prescription Arthritis Medications Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Prescription Arthritis Medications Revenue Market Share by Region (2020-2031)
 Figure 34. China Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Prescription Arthritis Medications Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Prescription Arthritis Medications Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Prescription Arthritis Medications Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Prescription Arthritis Medications Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Prescription Arthritis Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Prescription Arthritis Medications by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Prescription Arthritis Medications by Type (2020-2031)
 Figure 56. Global Prescription Arthritis Medications Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Prescription Arthritis Medications by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Prescription Arthritis Medications by Application (2020-2031)
 Figure 59. Global Prescription Arthritis Medications Price (USD/Unit) by Application (2020-2031)
 Figure 60. Prescription Arthritis Medications Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Prescription Orthopedic Drugs Market Research Report 2024
Arthritis Pain Injection Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prescription Respiratory Drugs Market Research Report 2024
Global Prescription Glasses Market Research Report 2024
Global Topical Medication Market Research Report 2024
Global Prescription Dermatological Medications Market Research Report 2024
Medicine for Osteoarthritis Pain Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Rheumatoid Arthritis RA Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rheumatoid Arthritis RA Medications Market Research Report 2025
Malaria Prescription Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prescription Management Service Market Research Report 2025
Arthritis Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Obesity Prescription Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Arthritis Gloves Market Research Report 2025
Rhematoid Arthritis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prescription Diet Market Research Report 2024
Global Electronic Prescription Service Market Research Report 2024
Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anticoagulant Medications Market Research Report 2024
Global Medication For Dairy Cows Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions